SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as the FDA reversed its prior refusal and will now review the company's seasonal influenza vaccine application, igniting bullish sentiment and sparking community discussion about a potential short squeeze.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending amid its new U.S. brewing partnership with Carlsberg and expanded UK pharmaceutical access, while the community is intensely focused on anticipated updates regarding the federal rescheduling of cannabis to Schedule III. Investors are sharply divided between those expecting a significant industry-wide catalyst and critics who highlight Tilray's limited direct benefit from U.S. cannabis reform as a Canadian LP.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is trending as its dedicated community rallies around a "Resist and Retire" narrative, positioning the crypto as a challenge to traditional financial systems. The project is gaining visibility through its climbing rank in crypto subreddits, active engagement, and ongoing initiatives like staking and real-world marketing.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending due to investor debate surrounding Nvidia's recent exit from its APLD stake. While some see it as a bearish signal, many in the community view it as Nvidia taking profits, with institutions reportedly buying the dip and confidence in APLD's AI data center fundamentals remaining robust.

Fiverr International Ltd. develops an e-commerce platform that allows people to buy and sell digital services. It operates through the following geographical segments: U.S., Europe, Asia Pacific, Rest of the World and Israel. The firm offers digital marketing, graphics and design, video and animation, writing and translation, and music and audio. The company was founded by Micha Kaufman and Shai Wininger in 2009 and is headquartered in Tel Aviv, Israel.

Fiverr International Ltd

Fiverr is trending as its recent earnings report, featuring disappointing guidance for the upcoming fiscal year, fuels intense community debate over its long-term viability. Investors are actively discussing the potential for AI to disrupt its core gig economy business model, leading to a largely bearish sentiment despite some arguing the stock is deeply undervalued.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending sharply lower as strong revenue and billings growth are overshadowed by a reduced profit outlook, driven by acquisition costs and AI security investments. The community is split, with many calling it an overreaction and a key buying opportunity, emphasizing that AI expansion will fundamentally increase, not diminish, the need for robust cybersecurity platforms.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge (SEDG) is trending following an earnings report that surpassed expectations, with community discussion intensely focused on the company's new collaboration to advance power infrastructure for AI data centers. This strategic move into high-growth adjacencies is driving significant bullish sentiment, overshadowing lingering concerns in the broader solar sector.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop is trending following its Q4 earnings report, where a significant beat on adjusted EPS overshadowed a revenue miss and a notable decline in domestic same-store sales, prompting cautious FY26 guidance. While some express concerns about valuation and softening domestic demand, the stock is seeing a strong rebound fueled by optimism around robust global unit expansion and operational improvements, alongside several analyst upgrades.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending as its IPO quiet period concludes, fueling community debate over its tight share float and potential for a short squeeze amidst anticipation for an FAA Space Launch license and broader sector interest driven by the upcoming SpaceX IPO, though some question its current business model and revenue.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is trending as an FDA PDUFA extension to March 16, 2026, for its dry eye drug sparks debate; bulls see the request for additional trial data as procedural given prior label discussions, while bears raise alarms over the recent CDO resignation and ongoing fraud investigations amidst the company's history of regulatory setbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

What is Brookline Cap M's Estimate for CRSP Q1 Earnings?

CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) - Brookline Cap M issued their Q1 2026 earnings per share estimates for CRISPR Therapeutics in a report released on Thursday, February 12th...

Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss)

Key PointsCRISPR Therapeutics' fourth quarter was relatively disappointing...

VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales

Vertex Q4 earnings miss estimates, but revenues top forecasts on strong CF sales and momentum from new launches like Alyftrek, Casgevy and Journavx.

CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 8% on Analyst Upgrade

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 8% Following Analyst Upgrade...

CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates

CRISPR Therapeutics posts a wider Q4 loss and revenues miss, but Casgevy sales climb, with label expansion plans and pipeline updates ahead.

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $82.00

Needham & Company LLC raised their price objective on CRISPR Therapeutics from $80.00 to $82.00 and gave the stock a "buy" rating in a research note on Friday...

CRISPR Therapeutics (NASDAQ:CRSP) Announces Quarterly Earnings Results

CRISPR Therapeutics (NASDAQ:CRSP - Get Free Report) posted its earnings results on Thursday. The company reported ($1.37) earnings per share for the quarter, missing the consensus estimate of ($1.16...

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Lags Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -18.85% and -78.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

CRISPR Therapeutics Earnings Report: Q4 Overview

CRISPR Therapeutics AG

Citi’s 2026 Virtual Oncology Leadership Summit

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

Current Price	$53.17
Prev Close	$53.07
Open	$53.00
Dividend Yield	0.00%
50-Day Moving Average	$54.33
Beta	1.57
Avg. Volume	1.84M
PE Ratio	-8.16

52-Week High	$78.48
52-Week Low	$30.04
Market Capitalization	$5.11B
EPS (Annual)	-$6.47
Price to Book	2.65
Revenue Per Employee	$8,931.30

CRSP
CRISPR Therapeutics AG

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRSP News

CRSPCRISPR Therapeutics AG